Macrophages are a heterogeneous cell type implicated in injury, repair, and fibrosis after AKI, but the macrophage population associated with each phase is unclear. In this study, we used a renal bilateral ischemiareperfusion injury mouse model to identify unique monocyte/macrophage populations by differential expression of Ly6C in CD11b + cells and to define the function of these cells in the pathophysiology of disease on the basis of microarray gene signatures and reduction strategies. Macrophage populations were isolated from kidney homogenates by fluorescence-activated cell sorting for whole genome microarray analysis. 
Renal ischemia-reperfusion injury (IRI) is one of the main clinical causes of AKI, 1,2 which is defined as an abrupt reduction in kidney function. Repair of the damaged tubular epithelium will result in full recovery in a subset of patients 3, 4 ; however, numerous recent clinical studies have identified associations between AKI, CKD, and progression to ESRD. [5] [6] [7] [8] Maladaptive repair leads to permanent structural and functional changes which culminate in tubulointerstitial fibrosis and chronic inflammation, central to CKD. 1, [9] [10] [11] Macrophages have been implicated in the injury, repair, and fibrosis associated with various renal diseases including AKI. 12, 13 In fact, CKD patients with high levels of interstitial macrophage infiltration have the poorest renal outcome. 14 Macrophages are a heterogeneous cell population that can switch from one phenotype to another in response to extracellular cues. 15 In vitro studies have defined the classically activated macrophages as proinflammatory, M1 macrophages, whereas the alternatively activated, M2 macrophages typically modulate the immune response to promote repair and fibrosis. 15, 16 The M2 classification has been further subdivided into M2 a-c . 13, 17 However, it is unclear how these populations defined in the in vitro setting with limited cytokine exposure will translate in vivo with more diverse cytokine signaling. Therefore, we have focused our efforts on defining macrophage populations based on their function during the pathophysiology of disease. 18 In this study, we use a murine model of renal IRI characterized by three different phases postreperfusion: injury, repair, and fibrosis, to identify the macrophage population associated with each phase. The populations are distinguished by differential Ly6C expression, which has been widely used to identify functionally discrete monocyte/macrophage populations. [18] [19] [20] [21] [22] [23] [24] [25] To establish their role in the pathophysiology of AKI, a small molecule c-fms inhibitor was used to inhibit macrophage proliferation and activation at different stages of disease. Furthermore, the newly identified populations of monocytes/macrophages were isolated and sorted from the kidney for microarray analysis. Our study is the first to show in the renal IRI model that each of the three populations carries a unique gene signature that provides insight into their functional role in the pathophysiology of acute and chronic disease following AKI.
RESULTS

In Vivo
Model of AKI Shows Distinct Phases of Injury, Repair, and Developing Fibrosis Samples were harvested for up to 35 days postreperfusion to define the timeframe of the various phases of the AKI model ( Figure 1A ). Plasma creatinine levels show that the loss of renal function is greatest 1 day postreperfusion, returning to baseline by 7 days ( Figure 1B) . A proinflammatory burst is measured in the kidney at 3 hours postreperfusion with peaks in mRNA expression of IL-6 and CXCL1 ( Figure 1C ). The return of plasma creatinine to normal levels is due to the surviving tubular epithelium dedifferentiating, proliferating and repolarizing to restore tubular structure and function. 4 Repair of the tubular epithelium is measured by proliferating cell nuclear antigen (PCNA) staining and vimentin mRNA expression with peaks in proliferation and dedifferentiation, respectively, quantitated 3 days postreperfusion ( Figure 1D ). Significant increases in extracellular matrix genes, fibronectin, collagen Ia1, and IIIa1 as well as the profibrotic gene, TGF-b1, are measured between 3 and 10 days postreperfusion ( Figure 1E and data not shown). This translates into histologic evidence of tubulointerstitial fibrosis measured by picrosirius red at 14 and 35 days ( Figure 1F ), demonstrating the long-term effects of renal IRI. Thus, based on the time points examined in this model, injury predominates in the acute phase for 1 day postreperfusion followed by repair that peaks at 3 days postreperfusion and declines by day 7 postreperfusion in agreement with published studies. 10, 26 Importantly, our study highlights that fibrosis develops from 7 to 35 days postreperfusion following bilateral renal IRI. (Figure 2A ). All three populations are present in the normal kidney at low levels. Correlating with the proinflammatory burst at 3 hours postreperfusion ( Figure 1C ), elevated numbers of the Ly6C high population are measured, which are F4/80 low ( Figure 2 , A+inset, C). The Ly6C int population appears at 3 hours postreperfusion and persists as the dominant population at 3 days with varying levels of F4/80 expression ( Figure 2 , A+inset, C). PCNA staining and vimentin expression peak at this time ( Figure 1D ), suggesting this population may be involved in repair. Finally, the Ly6C 27 Moreover, inhibition of the c-fms receptor which mediates proliferation, differentiation and survival of monocytes/ macrophages 28 when bound to colony-stimulating factor demonstrates that inhibition of monocytes/macrophages prior to IRI ( Figure 3A ) dampens the proinflammatory milieu leading to renoprotection. An approximately 50% decrease is measured 2 hours postreperfusion in kidney mRNA expression of IL-6 (Figure 3F ) and CXCL1 ( Figure 3G ), with significant reductions in IL-6 at 1 day. Significant reductions in plasma creatinine ( Figure  3D ), BUN (data not shown), kidney injury molecule-1 (KIM-1; Figure 3E ), and neutrophil gelatinase-associated lipocalin (NGAL; data not shown) are measured and a decrease in kidney CD11b + /F4/80 cells ( Figure 3B ) and circulating monocytes ( Figure 3C ) persists.
However, when the c-fms inhibitor is administered 1-3 days postreperfusion ( Figure 4A ) when tubular epithelial proliferation and vimentin expression are at peak levels ( Figure 1D ), there is a significant decline in kidney repair. Cellular proliferation measured by PCNA staining of the tubular epithelium in the cortex and outer medulla is significantly decreased (Figure 4D ) concomitant with a significant increase in cell death measured by terminal deoxynucleotidyl transferase-mediated digoxigenin-deoxyuridine nick-end labeling (TUNEL; Figure  4E ). There are trends of increased KIM-1 and NGAL mRNA expression (P=0.19 and 0.10, respectively; data not shown) yet no difference in plasma creatinine is measured (data not shown). Total kidney CD11b + /F4/80 + cells ( Figure 4B ) are significantly decreased with c-fms inhibitor treatment. Importantly, further analysis of CD11b + /Ly6C + cells demonstrates that the Ly6C int population is significantly reduced by approximately 50% (P,0.05), whereas the Ly6C high and Ly6C low populations remain equivalent ( Figure 4C) . Thus, the cell proliferation and death data jointly suggest a role of the Ly6C int population in kidney repair.
Genomic Analysis Identifies a Unique Gene Signature for Each Macrophage Population As there are conflicting reports on the role of macrophages in fibrosis based on studies with liposome clodronate 29 and the c-fms inhibitor, 30 a genomic approach was taken. Single-cell suspensions of kidney homogenates were flow-sorted based on CD11b/Ly6C expression to isolate each population followed by whole genome array. Based on hierarchical cluster analysis, a unique gene signature is identified for each population ( Figure 5A ). Principal component analysis confirms the differential gene expression in each population ( Figure 5B) .
A number of differentially expressed genes highlight the distinct phenotypes of the populations. The CD11b + /Ly6C high population carries a gene signature associated with the monocyte/macrophage immune response and monocyte/macrophage differentiation ( Figure 6D ). In contrast, the CD11b + /Ly6C int population expresses numerous genes associated with wound healing ( Figure 6A ) and the CD11b + /Ly6C low population expresses genes associated with fibrosis ( Figure 6A ). Interestingly, both macrophage populations express a variety of chemokines, membrane receptors, and inflammation-associated genes, suggesting both carry an inflammatory signature ( Figure 6B) ; however, complementassociated genes are exclusively expressed by the Ly6C low population ( Figure 6A ). The expression of M2-specific macrophage markers such as Arg1, CD74, Chi3l3, and Mrc1 suggest that both populations may be considered M2 macrophages; however, only Chi3l3 and Mrc1 would be useful to distinguish between them ( Figure 6A ). A subset of genes was confirmed by quantitative RT-PCR (qRT-PCR) and the results verify the accuracy of the microarray analysis ( Figure 6C ).
The top 15 cell processes associated with the genes uniquely upregulated in the Ly6C int population were identified using Pathway Studio software. The majority of the cell processes (Table 1) . Importantly, these data further support our hypothesis that the Ly6C int population plays a role in repair following AKI. Querying published microarray data sets using NextBio identified statistically significant strong correlations between the genes upregulated in the Ly6C int population and several studies of macrophages activated in culture systems with various stimuli, indicating that the Ly6C int population represents activated macrophages (Table 2) .
Statistically significant, strong correlations also were identified between the genes upregulated in the Ly6C low population and several studies analyzing fibrotic tissues, including mouse lung tissue treated with bleomycin to induce fibrosis, and cirrhotic liver and kidney biopsies from human patients with interstitial fibrosis at 1 year post-transplant (Table 3) . Importantly, these data support our hypothesis that the Ly6C low population is involved with the fibrosis that develops following renal IRI.
DISCUSSION
Macrophage infiltration into the kidney correlates with decline in kidney function of patients with CKD. 14 These data suggest that macrophages play a critical role in the progression of kidney disease; however, the mechanism remains unclear. Our study is the first to phenotype and define a functional role of monocytes/macrophages based on differential Ly6C expression over time in the pathophysiology of renal IRI. Three unique subsets of monocytes/ macrophages that correlate with injury, repair, or fibrosis were identified. Wholegenome analysis of the three different subsets identified a distinct gene signature for each that provided insight into the role of the 1 day postreperfusion, declining thereafter. *P#0.05 indicates a significant difference from all time points of the respective population. # P#0.05 indicates a significant difference from all time points of the respective population except 3 days.^P#0.05 indicates a significant difference from all time points of the respective population except 35 days. n=4 for all groups except 10 days which has n=6. Ly6C high in injury, the Ly6C int population in repair, and the Ly6C low population in fibrosis. It also highlighted that these populations do not fit into the canonical M1/M2 classifications defined by in vitro assays. Finally, these data provide insight into mechanisms by which monocytes/macrophages contribute to acute and chronic disease following renal IRI.
Differential Ly6C expression has been widely used to identify functionally discrete monocyte/macrophage populations. [18] [19] [20] [21] [22] [23] [24] [25] In a murine model of kidney fibrosis by unilateral ureteral obstruction (UUO), three different populations of macrophages were identified by differential Ly6C expression. 19 Our data confirm and extend these findings. Similarly, we show that one of the first populations to appear in the renal IRI model is the CD11b Moreover, similar to Duffield's findings in the UUO model, 19 our microarray studies in the renal IRI model implicate the CD11b + /Ly6C low population as profibrotic. We identified similar (Igf1) yet novel genes (Parp1, TRPM7, SPARC, ROCK1), confirming a role in kidney fibrosis of the CD11b + /Ly6C low population. However, in other organs, such as the liver in a model of reversible fibrosis, the Ly6C low population is involved in the resolution of fibrosis while the Ly6C high population drives fibrosis. 18 In a model of myocardial infarction, the Ly6C high population scavenged necrotic debris while the Ly6C low population was implicated in reparative processes. 25 Thus, the phenotype of a particular Ly6C population may differ based on organ and pathophysiology of disease. Therefore, as suggested by Murray et al., 31 studies should focus on the function of the macrophage rather than definition by cell surface marker expression.
Additional rationale to focus on macrophage function comes from our data in which we show that the Ly6C int and Ly6C low populations do not fit into the canonical M1/M2 classifications defined by in vitro assays. The M2 markers, Arg1 and CD74, are expressed in both populations; however, the M2 markers, Chi3l3 and Mrc1, are expressed only in the Ly6C int and Ly6C low populations, respectively. No M1 markers are detected in any population. The nomenclature of M1 and M2 macrophages was based on in vitro studies in which cells were exposed to one cytokine; however, in the disease setting there will be a milieu of various cytokines so the classification of macrophages based on cell surface marker expression becomes complex. 31 Thus, in light of current efforts to harmonize nomenclature for macrophage studies, 31 we have focused our studies on defining macrophage populations based on function. The origin of the macrophage subsets may also vary based on organ and disease. Recruitment and differentiation of Ly6C high monocytes were identified as the primary source of profibrotic macrophages in a UUO model. 19 In a study focused on reparative macrophages following renal IRI, recruitment of monocytes as well as in situ proliferation of resident macrophages were shown to contribute to increases in the reparative population. 32 In a liver fibrosis model, Ly6C high monocytes differentiated into two different macrophage subsets: profibrotic and proresolution. 18 In a myocardial infarction model, two different subsets of monocytes were recruited to differentiate into two different subsets of macrophages. 25 Our data show that Ly6C expression decreases while F4/80 expression increases over time, suggesting that the Ly6C high subset may be more monocytic while the Ly6C low subset is more mature. This is supported by the expression of genes in the low population associated with macrophage differentiation from monocytes including: Mcm6 33 and Nrp1 (neuropilin-1). 34 Also, chemokines and membrane receptors expressed in both the Ly6C int and low populations, including Cxcl14, Cxcl3, Csf1r, and Cx3cr1, have been linked to the recruitment of monocytes. 35, 36 Collectively, these data suggest that monocyte recruitment and resident cell proliferation are likely to be essential for the expansion of the macrophage populations in our studies, but further experiments would be required to confirm.
Several groups have examined the deleterious role of macrophages in renal IRI by demonstrating renoprotection after reducing macrophage number by genetic deletion of Ccr2 and Cx3cr1 37 or treatment with liposome clodronate, 26,38 a widely accepted means of inducing macrophage apoptosis. 39 Macrophages have also been linked to kidney repair following AKI by using liposome clodronate during the recovery phase to deplete macrophages, leading to reduced proliferation of the tubular epithelium. 26, 32 In our studies, we use a small molecule inhibitor of c-fms to prevent the differentiation and activation of macrophages and confirm published reports showing that macrophages are involved in both the injury and repair phases of renal IRI. 26, 32, 40 Moreover, we extend this observation by gene expression analysis. Further studies are needed to determine whether the Ly6C int population arises from the Ly6C high population or whether the gene expression profile of the Ly6C int population changes to one of repair from 3 hours to 1 day postreperfusion.
To understand potential mechanisms by which macrophages regulate injury and repair, our strategy was to focus only on genes uniquely expressed in each population without consideration of genes that are up-or downregulated in each respective phenotype over time. A limitation of the analysis is that we are also comparing cell populations harvested at different time points when sufficient cells were present to harvest RNA. Moreover, we cannot rule out that gene expression profiles could be altered through the tissueprocessing and cell-sorting procedure. Because CD11b and Ly6C can be expressed on dendritic cells and neutrophils, we must also consider that these cells could be present in our sorted populations.
Several genes upregulated in the Ly6C high population are linked with the monocyte/macrophage immune response. Apoc1 and Met associate with monocyte-macrophage differentiation, 41, 42 whereas Egf mediates monocyte/macrophage chemotaxis. 43 Sell (L-selectin) facilitates cell adhesion and rolling. Importantly, analysis of the cell processes linked to the Ly6C int subset indicate a role in cell differentiation, tissue remodeling, phagocytosis and vascularization, which are all key processes in repair of the tubular epithelium. Mmp8 contributes to the resolution of inflammation, 44 while Mmp9 regulates re-epithelialization and collagen fibril formation during wound repair. 45 Chi3l1 encodes a protein secreted by macrophages that mediates kidney repair by limiting tubular cell death, 46 which may explain the increased cell death with c-fms inhibitor treatment. Collectively, these data clearly indicate the Ly6C int subset plays a paracrine role in repair of the tubular epithelium.
Due to the inconsistent reports about depleting macrophages to establish a role in kidney fibrosis, 29, 30 we investigated the gene signature of the Ly6C low population. One key piece of evidence supporting a role in fibrosis is the common gene signature identified between the Ly6C low population and numerous genomic studies linked to fibrotic diseases including kidney transplant patients that have interstitial fibrosis. 47, 48 Additionally, several genes are directly linked to fibrosis. SPARC regulates the expression of secreted extracellular matrix proteins to mediate fibrosis 49, 50 while Timp2 inhibits extracellular matrix turnover by matrix metalloproteinases (MMPs) leading to matrix accumulation. 51 Igf1 released by macrophages may attenuate myofibroblast apoptosis 52 or stimulate type I collagen release. 53 Activation of complement is involved in progressive tubulointerstitial disease. 54 Clearly, the genetic signature of the Ly6C low population indicates that it contributes to kidney fibrosis.
Incomplete repair of the tubular epithelium following AKI leads to progressive kidney disease driven by chronic inflammation, tubulointerstitial fibrosis, and vascular dropout. 9, 10, 55 Our data indicate that one subset of macrophages has a beneficial role in repair of the tubular epithelium, while another has a detrimental role in the progression to chronic disease following AKI. Interestingly, both populations have an inflammatory signature and we propose, based on our data and clinical studies showing that CKD is a proinflammatory state, 56 that it is the chronic inflammation which develops following acute injury that drives the progression to CKD. Because it is unknown whether there is a dynamic relationship between the different subsets of macrophages, the best therapeutic approach may be to target macrophage paracrine signaling. Our microarray analyses identified several genes which may be key contributors to repair of the kidney or progressive fibrosis. Future studies should aim to determine whether enhancing repair or minimizing fibrosis and inflammation would improve patient outcome.
CONCISE METHODS
Please refer to the Detailed Methods in the online Supplemental Material for additional information.
Mouse Model of Bilateral Renal IRI
In vivo studies were approved by the Genzyme Institutional Animal Care and Use Committee. C57BL/6 male mice (8-10 weeks, Taconic, Germantown, NY) underwent bilateral renal IRI for 28 min or sham surgery followed by reperfusion for various times as previously described. 11 Surgery was carried out through bilateral flank incisions with animals on homeothermic operating tables to maintain body temperature at 37°C through rectal probe during the ischemia and reperfusion episodes. After surgery, animals were hydrated with intraperitoneal injection of 1 ml sterile saline. Pain medication (buprenorphine, 0.05 mg/kg, SC) was administered before surgery and then again at 12-hr intervals for 2 days starting 24 hours later. Sham surgeries were identical without the bilateral clamping. At sacrifice, retro-orbital blood was collected followed by whole-body perfusion. Harvested kidneys were snap-frozen for molecular analysis, minced for flow-cytometric analysis or fixed for paraffin embedding and processing as previously described. 11 Plasma creatinine and BUN values were measured on a Roche Integra 400 Bioanalyzer (Roche Diagnostics, Indianapolis, IN). Whole blood was analyzed for circulating monocytes (Sysmex XT-V Automated Hematology Analyzer; Sysmex, Kobe, Japan). A small molecule inhibitor of c-fms kinase activity (30 mg/kg, PO) was used to reduce monocyte/macrophage proliferation, differentiation and survival, based on published reports. 30, 57 
Morphologic Analysis
Picrosirius red staining and immunostaining of proliferating cell nuclear antigen (PCNA; Abcam, Inc.) and TUNEL (ApopTag Red Apoptosis Determination Kit; EMD Millipore) were carried out as previously detailed. 11, 58, 59 To quantify reactivity in kidney tubules, four to six random fields of the outer medulla or cortex per section per animal were photographed at 203 followed by Metamorph analysis (Molecular Devices, Sunnyvale, CA). Data are expressed as mean6SEM.
Quantitative RT-PCR
For qRT-PCR, total RNA was extracted from snap-frozen tissues with the RNeasy Kit (Qiagen, Valencia, CA) and reverse-transcribed to cDNA (Clontech, Mountain View, CA), as previously described. 11 Probes and primers specific for mouse (Applied Biosystems, Foster City, CA) included IL-6 (Mm00446190_m1), CXCL1 (Mm04207460_m1), fibronectin (Mm01256744_m1), TGFb1 (Mm01178820_m1), KIM-1 (Mm00506686_m1), NGAL (Mm01324470_m1), CXCL3 (Mm017018 38_m1), IGF 1 (Mm0043 9560_m1), C3AR1 (Mm026200 06_s1), PARP1 (Mm013210 84_m1), CD7 4 (Mm00658576_m1), MMP8 (Mm00439509_m1), and MMP9 (Mm00442991_m1). Data were normalized to 18S (Hs99999901_s1) and expressed as fold change compared with normal.
Flow Cytometry
For flow cytometry, single-cell suspensions of the kidney were made by digesting the tissue in 1 mg/ml collagenase B, 1.2 U/mL dispase, 5 U/mL DNase II followed by a series of filtering and washing as described. 58 
Microarray Analysis
Time points for microarray analysis were selected when the Ly6C population of interest dominated to optimize mRNA isolation and amplification. Cell populations were sorted on a BD FACSARIA II cell sorter (BD Bioscience) based on CD11b + /Ly6C high, intermediate or low for RNA isolation (Qiagen) and amplification (NuGen Ovation Pico WTA v2, NuGen Technologies, San Carlos, CA) for cDNA production. The amplified cDNA library was further fragmented and labeled with NuGen Encore Biotin Module (NuGen Technologies) followed by hybridization to Affymetrix GeneChip Mouse Genome 430 2.0 array. Raw CEL files were robust multiarray average preprocessed in Affymetrix Expression Console and imported into Array Studio v6.1 (OmicSoft, Cary, NC) for further downstream statistical analysis. The expression data set was filtered to reduce background noise and median normalized across filtered probes. Principal Component Analysis separated ischemia and sham kidneys. Inference reports (t tests) were generated for IRI and sham group separated by population and time course as well as overall IRI versus sham. Similarly, hierarchical clustering was performed to show differentially expressed genes between IRI versus Sham. Statistical significance was set at P,0.01 with no multiple testing correction. To understand potential mechanisms by which macrophages regulate injury, repair and fibrosis, our strategy was to focus only on genes uniquely expressed in each population without consideration of genes that are up-or downregulated in each respective phenotype over time. Differentially expressed gene lists (FC61.5, P,0.01) from comparative analysis were correlated to public gene expression repository with commercial software NextBio (NextBio, Cupertino, CA). Links between genes and cell processes/phenotype were identified with Pathway Studio (Ariadne Genomics, Rockville, MD). One-way ANOVA followed by the Newman-Keuls multiple comparison test and two-way ANOVA followed by Sidak's multiple comparison test or t tests were used when appropriate to determine statistical differences using GraphPad Prism v6.0 software (GraphPad Software, Inc., La Jolla, CA). Data are expressed as mean6SD, unless otherwise indicated. 
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